Your browser doesn't support javascript.
loading
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT.
Nakano, Nobuaki; Utsunomiya, Atae; Matsuo, Keitaro; Yoshida, Noriaki; Seto, Masao; Ohshima, Kouichi; Fujiwara, Hiroshi; Fuji, Shigeo; Takatsuka, Yoshifusa; Ito, Ayumu; Miyamoto, Toshihiro; Suehiro, Youko; Nakamae, Hirohisa; Sawayama, Yasushi; Yuasa, Mitsuhiro; Miyazaki, Yasuhiko; Ota, Shuichi; Imada, Kazunori; Fukuda, Takahiro; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kato, Koji.
Afiliación
  • Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Utsunomiya A; ATL Working Group of Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Matsuo K; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Yoshida N; ATL Working Group of Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Seto M; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Ohshima K; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fujiwara H; Department of Pathology, Kurume University, Kurume, Japan.
  • Fuji S; Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.
  • Takatsuka Y; Department of Pathology, Kurume University, Kurume, Japan.
  • Ito A; Department of Pathology, Kurume University, Kurume, Japan.
  • Miyamoto T; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
  • Suehiro Y; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Nakamae H; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Sawayama Y; ATL Working Group of Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Yuasa M; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Miyazaki Y; Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ota S; Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan.
  • Imada K; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Fukuda T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Ichinohe T; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
  • Atsuta Y; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Kato K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Blood Adv ; 5(2): 475-486, 2021 01 26.
Article en En | MEDLINE | ID: mdl-33496743
Adult T-cell leukemia/lymphoma (ATL) cells frequently exhibit chromosomal abnormalities, including numerical aberrations and structural defects. However, no studies have examined the correlation between these abnormalities and survival in patients with ATL after allogeneic HSCT (allo-HSCT). In this study, 300 patients with ATL (median age, 55 years; range, 24-74) who were registered in a Japanese nationwide registry database were analyzed. The majority (n = 183) had acute ATL. Specimens for chromosomal analysis were collected from bone marrow (n = 166), lymph nodes (n = 86), peripheral blood (n = 41), and other locations (n = 7). In survival analyses, breakpoints at 2q (hazard ratio [HR], 1.63; 95% confidence interval [CI], 1.12-2.38; P = .012) and 5q (HR, 2.18; 95% CI, 1.25-3.80; P = .006) were significantly poor prognostic factors for overall survival (OS). In terms of ATL-related death, loss of chromosome 14 and breakpoints at 3p, 1q, 5q, and 6q were extracted as significantly poor prognostic factors. Moreover, complex karyotypes were associated with ATL-related death. This study of the survival impact of chromosomal abnormalities in patients with ATL after allo-HSCT demonstrated that several structural breakpoints were independent risk factors for OS and ATL-related death.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma de Células T del Adulto / Trasplante de Células Madre Hematopoyéticas / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma de Células T del Adulto / Trasplante de Células Madre Hematopoyéticas / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article País de afiliación: Japón